Free Trial
TSE:ACB

Aurora Cannabis 8/7/2024 Earnings Report

Aurora Cannabis logo
C$6.92 +0.25 (+3.75%)
As of 08/22/2025 04:00 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
-C$0.16
Consensus EPS
-C$0.48
Beat/Miss
Beat by +C$0.32
One Year Ago EPS
N/A

Aurora Cannabis Revenue Results

Actual Revenue
$92.04 million
Expected Revenue
$76.70 million
Beat/Miss
Beat by +$15.34 million
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Aurora Cannabis Earnings Headlines

Atb Cap Markets Comments on Aurora Cannabis Q2 Earnings
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Aurora Cannabis Shines in Earnings Call Despite Challenges
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile

More Earnings Resources from MarketBeat